North Central London - Cancer Commissioning Guide & High-Level Intentions for 2025-26

22 | Cancer Commissioning Strategy Framework Cancer Commissioning Strategy Framework | 23 Appendix 3 - Fragile Services Framework MEASURE CA TEGORY DETAILS MEASURE 1. Service Capacity and Demand Analysis Evaluate patient volume versus available resources. 1. Total number of patients served vs. outpatient appointments per month. 2. Total number of patients served vs. theatre capacity per month. 3. Total number of patients served vs. diagnostic capacity per month. 4. Analysis of average wait times for treatment per tumour per month. Assess staffing levels, equipment availability, and facility capacity. 1. Ratio of healthcare staff to patients per month. 2. Inventory of medical equipment. Medical equipment utilisation rate %. 2. Quality and Safety Metrics Monitor treatment outcomes, patient satisfaction, and adherence to clinical guidelines. 1. Percentage of patients with successful treatment outcomes per month. 2. Patient satisfaction scores from outpatient friend and family test per year. 3. Compliance rate with NICE guidelines per year. Include measures for error rates and complication rates in treatments. 1. Incidence of treatment-related complications and errors per 1000 treatments. 2. Reporting of incidents through new PSIRF and LFPSE systems per month. 3. Financial Sustainability Analyse cost-effectiveness of services. 1. Average cost per service by tumour type. Consider funding sources and financial stability of the service. 1. Percentage of budget from permanent (ICB) funding per year. 2. Percentage of budget from non-permanent funding (CA, transformation, contracts). 3. Year-over-year financial performance of cancer services. 4. Workforce Stability Assess staff turnover rates and training levels. 1. Annual staff turnover rate per year. Evaluate the staff MDT effectiveness. 2. Average number of years of experience per staff member per year. 1. Ratio of specialised to general staff in the oncology department. 2. Frequency of multidisciplinary case reviews for cancer patients. 3. Completion of staging data. Appendix 3 - Fragile Services Framework MEASURE CATEGORY DETAILS MEASURE 5. Patient Accessibility and Equity Measure accessibility for different patient groups. 1. Percentage of patients treated from various demographic/ deprivation /protected characteristic groups. Assess service availability across geographic locations. 1. Average distance patients travel for treatment. 2. Number of outreach programs or services in underserved areas. 6. Integration and Coordination Evaluate how well services are integrated with other healthcare services. 1. Number of integrated care pathways for cancer patients. 2. Time from referral from primary care to first oncology appointment per month. 3. Average diagnostic turnaround times per month. 7. Adaptability and Innovation Assess the service's ability to adapt to changing healthcare needs and integrate new treatments and technologies. Time to adoption of digital innovation (time from proposal, approval and implementation). Time to adoption of NON digital innovation (time from proposal, approval and implementation). Cost of decision making. Number of projects ongoing or completed in the last fiscal year. *No. of Pilots. *No. of adopted/BAU projects. Number of clinical trials conducted or participated in, in the last fiscal year. Number of conducted or participated in research projects in the last fiscal year. Number of projects conducted or participated in, the last fiscal year. Appendix 3 - Fragile Services Framework

RkJQdWJsaXNoZXIy NTI5NzM=